Novavax live chart

Mga Pangunahing Kaalaman sa Instrumento

Weekly Search
Weekly
Daily
Petsa Isarado Pagbabago Change (%) Buksan High Low

Novavax news

2021 Mayo 11, 13:20

US pre-market: selling unabated

2021 Mayo 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 Mayo 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Mga pinakabagong balita

Ipakita nang marami
Ava Grace 2025 Sep 12, 15:20

Market Review: Dollar Fluctuations, Gold Surges, and Interest Rate Adjustments

Noah Lee 2025 Sep 12, 15:20

US Consumer Confidence Plunges in September Amid Rising Inflation Fears

Noah Lee 2025 Sep 12, 14:20

Trump Threatens Russia with New Sanctions Over Ukraine: 'My Patience is Running Out'

Ava Grace 2025 Sep 12, 12:20

Poland Rejects Trump's 'Mistake' Claim on Drone Incursion, Calls it 'Deliberate Russian Attack'

Noah Lee 2025 Sep 12, 10:20

US-Japan Joint Statement: Reaffirming Market-Driven Exchange Rates

Emma Rose 2025 Sep 12, 09:20

Goldman Sachs, UBS Raise Gold Price Forecasts for 2025

Noah Lee 2025 Sep 12, 09:20

Albania Appoints AI Minister to Combat Corruption in Public Procurement

Emma Rose 2025 Sep 11, 15:20

Dalio: Gold as a Hedge Against Mounting Debt Risks

Info

Spread

0.05

Spread (%)

0.6281 %

Leverage

1:10

Interes sa Magdamagang Pagbili

-0.0597 %

Interes sa Magdamagang Pagtinda

-0.0292 %

Currency

USD

Trading Hours

Oras ng Pagsasara

Lunes

13:31 - 19:59

Martes

13:31-19:59

Miyerkules

13:31-19:59

Huwebes

13:31-19:59

Biyernes

13:31-19:59

Analys och statistik

Buksan

---

Nakaraang Pagsara

---

52 Linggo Mataas/Mababa

--- – ---

Market Cap

1296127616

Natitirang Pagbabahagi

162422000

Petsa ng Mga Kita (Susunod)

2019-05-10

Pambayad si dividend

2019-05-10

Araw ng Pag-alis ng Karapatan sa Dividend

Inaasahang Taunang Rate ng Dividend

0

Inaasahang Taunang Dividend Yield

0

EPS

2.22

Alamin ang Higit Pa Tungkol sa Instrumentong ito

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Mga kaugnay na instrumento

view_all_instruments

latest_education_articles

Ipakita nang marami
Trustpilot